Psychedelics are currently illegal for medical use in most of the United States. However, more trials and research are underway.
Lynn Marie Morski, president of Psychedelic Medicine Association and medical director of Nue Life Health, said that many psychedelics are in trial phrases to become FDA approved.
The psychedelic furthest along in these trials is MDMA, which is used to treat PTSD. Morski explained that patients with PTSD perform MDMA-assisted psychotherapy with two therapists for eight hours.
“In the phase three trials something like 67 percent of the patients who have long standing PTSD are doing this MDMA assisted psychotherapy and following the course of therapy, they are taking the CAPS scale, which tells the practitioner do they have PTSD,” Morski said. “They are taking the CAPS scale test, and they’re not qualifying as even having PTSD anymore.”
Other psychedelics such as psilocybin, LSD and DMT are being tested as treatment for severe headaches, depression, and even as recovery from a stroke. However, most of these psychedelics are still in the first phase of trials.
There are many questions about whether Indiana would adopt psychedelic usage for medical use. In Indiana, psychedelic use of any kind is illegal and many wonder if Indiana will ever accept these practices due to its hard stance on drugs in the past, including marijuana. Jeff Mease, a psychedelic enthusiast and activist, says in order for people to accept psychedelic usage, we need to know more.
“They don’t really understand that a Schedule 1 substance has been almost impossible to study, we block our scientists from things,” Mease said.
Mease calls the last 50 years a dark age for psychedelic study. However, he said with the resurgence of research, we can begin to learn more about the use of psychedelics to help with medical treatment.
